chirality, as demonstrated by Burgess.5 To the best of our
knowledge, however, only symmetrically substituted bis(1,2,3-
triazoles) 1-3 have been prepared to date,6 and no practical
method for the synthesis of the unsymmetrically substituted
counterparts is known.7
We reasoned that the desired 4-ethynyltriazoles 5 could
be obtained from the readily available 4-hydroxymethyl
derivatives 8 through a two-step procedure involving the
Swern oxidation followed by the Ohira-Bestmann alkyny-
lation.14 As disclosed in Table 1, the Cu(I)-catalyzed click
Herein we report an approach to unsymmetrically disub-
stituted bis-1,2,3-triazoles (Scheme 1) involving a “click”
Table 1. Stepwise Preparation of 4-Ethynyl-1,2,3-triazoles 5
Scheme 1. Retrosynthesis of 4,4′-Disubstituted
Bis(1,2,3-triazoles) 4 from 4-Ethynylmonotriazoles 5 and Azides
6
disconnection into 4-ethynyl-1,2,3-triazoles 5 and azides 6.
The synthesis of 4-alkynyl-1,2,3-triazoles 5 was itself
challenging. Not surprisingly, the thermal cycloaddition of
terminal diacetylenes with 1 equiv of benzyl azide resulted
in mixtures of 1,4- and 1,5-regioisomers of bis-triazoles
together with small amounts of the desired 4-ethynyl-1,2,3-
triazole.8 Tykwinski et al. have reported the regioselective
trapping of terminal di-, tri-, and tetraynes with benzyl azide
to afford alkynyl-, butadiynyl-, and hexatriynyltriazoles in
moderate to good yields.9 4-Ethynyl-1,2,3-triazoles or their
trimethylsilyl-protected counterparts were also prepared as
antibacterial agents10 or tachykinin receptor antagonists.11
On the other hand, Hawker et al. have employed the azide/
acetylene coupling of 1-trimethylsilyl-2-vinylacetylene12 or
propargyl alcohol13 with azides to prepare vinyl-1,2,3-
triazolyl monomers.
a CuSO4, Na ascorbate, t-BuOH/H2O: 1/1. b Yields of pure isolated
products. c TBTA (1 mol %) was used as an additive. d Spontaneous
debenzylation of 8f was observed during the alkynylation step to give the
corresponding triazolyl carboxylic acid instead of the expected benzyl ester.
Theacidwasthensubmittedtomethylationto5iwithtrimethylsilyldiazomethane.
e Yield of the methyl ester 5i (see Table 3).
(5) Angell, Y.; Burgess, K. Angew. Chem., Int. Ed. 2007, 46, 3649–
3651.
(6) (a) Monkowius, U.; Ritter, S.; Ko¨nig, B.; Zabel, M.; Yersin, H. Eur.
J. Inorg. Chem. 2007, 459, 7–4606. (b) Fletcher, J. T.; Bumgarner, B.;
Engels, N. D.; Skoglund, D. A. Organometallics 2008, 27, 5430–5433.
(7) A stepwise double-click strategy has been applied successfully to
the preparation of R,ω-bis(1,2,3-triazolyl)peptides; see: (a) Aucagne, V.;
Leigh, D. A. Org. Lett. 2006, 8, 4505–4507. For an iterative synthesis of
triazolamers containing amino acids side chains, see: (b) Angelo, N. G;
Arora, P. S. J. Am. Chem. Soc. 2005, 127, 17134-17135and J. Org. Chem.
2007, 72, 7963-7967. Oligomeric peptidomimetic compounds were
synthesized from orthogonally protected 1,4-disubstituted-1,2,3-triazoles,
see: (c) Montagnat, O. D.; Lessene, G.; Hughes, A. B. Tetrahedron Lett.
2006, 47, 6971–6974.
reactions of propargyl alcohol 7 with different azides (6a-f)
proceeded in 72-99% yields, but catalytic amounts (1-5%)
of TBTA15 were required when sterically hindered azides
were used (entries 3, 4, and 6, Table 1). Alkynyltriazoles
5a-c were prepared in good overall yields; however, when
benzyl ester and O-acetyl protective groups were present,
the final alkynylation step was problematic, leading to
complicated reaction crudes and low yields of the expected
products (entries 4-6).
Obviously, the conditions of the Swern oxidation step also
limited the method to azide residues (R1) bearing no
oxidation-sensitive groups (e.g., hydroxyl groups). To over-
come these important limitations, we implemented a different
synthetic approach starting from commercial 1,4-bis(trim-
ethylsilyl)butadiyne 9. Accordingly, chemoselective desily-
(8) Tikhonova, L. G.; Serebryakova, E. S.; Proidakov, A. G.; Sokolova,
I. E.; Vereshchagin, L. I. J. Org. Chem. USSR 1981, 17, 645–648.
(9) Luu, T.; McDonald, R.; Tykwinski, R. R. Org. Lett. 2006, 8, 6035–
6038.
(10) (a) Reck, F.; Zhou, F.; Girardot, M.; Kern, G.; Eyermann, C. J.;
Hales, N. J.; Ramsay, R. R.; Gravestock, M. B. J. Med. Chem. 2005, 48,
499–506. (b) Josyula, V. P. V. N.; Boyer, F. E., Jr.; Kim, J.-Y. PCT Int.
Appl. WO 2007/000644 A1.
(11) Amegadzie, A. K.; Gardinier, K. M.; Hembre, E. J.; Hong, J. E.;
Jungheim, L. N.; Muehl, B. S.; Remick, D. M.; Robertson, M. A.; Savin,
K. A. PCT Int. Appl. WO 03/091227 A1.
(12) Thibault, R. J.; Takizawa, K.; Lowenheilm, P.; Helms, B.; Mynar,
J.; Fre´chet, J. M. J.; Hawker, C. J. J. Am. Chem. Soc. 2006, 128, 12084–
12085.
(14) (a) Ohira, S. Synth. Commun. 1989, 19, 561–564. (b) Mu¨ller, S.;
Liepold, B.; Roth, G. J.; Bestmann, H. J. Synlett 1996, 521–522.
(15) Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA): Chan,
T. R.; Hilgraf, R.; Sharpless, K. B.; Fokin, V. V. Org. Lett. 2004, 6, 2853–
2855.
(13) Takizawa, K.; Nulwala, H.; Thibault, R. J.; Lowenheilm, P.;
Yoshinaga, K.; Wooley, K. L.; Hawker, C. J. J. Polym. Sci., Part A 2008,
2897–2912.
Org. Lett., Vol. 12, No. 7, 2010
1585